Medical Care
Global Myasthenia Gravis Treatment Market Insights, Forecast to 2030
- Mar 11, 25
- ID: 5073
- Pages: 111
- Figures: 134
- Views: 15
Market Analysis and Insights: Global Myasthenia Gravis Treatment Market
The global Myasthenia Gravis Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Myasthenia Gravis Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Myasthenia Gravis Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Myasthenia Gravis Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Myasthenia Gravis Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Myasthenia Gravis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Myasthenia Gravis Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Alexion Pharmaceutical Inc.
Grifols SA
Avadel Pharmaceuticals plc.
Novartis AG
Pfizer; Inc.
AbbVie Inc.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Bausch Health Companies Inc.
Shire plc.
Segment by Type
Medication
Surgery
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Myasthenia Gravis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Myasthenia Gravis Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Myasthenia Gravis Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
The global Myasthenia Gravis Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Myasthenia Gravis Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Myasthenia Gravis Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Myasthenia Gravis Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Myasthenia Gravis Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Myasthenia Gravis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Myasthenia Gravis Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Alexion Pharmaceutical Inc.
Grifols SA
Avadel Pharmaceuticals plc.
Novartis AG
Pfizer; Inc.
AbbVie Inc.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Bausch Health Companies Inc.
Shire plc.
Segment by Type
Medication
Surgery
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Myasthenia Gravis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Myasthenia Gravis Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Myasthenia Gravis Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myasthenia Gravis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Medication
1.2.3 Surgery
1.3 Market by Application
1.3.1 Global Myasthenia Gravis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Myasthenia Gravis Treatment Market Perspective (2019-2030)
2.2 Global Myasthenia Gravis Treatment Growth Trends by Region
2.2.1 Myasthenia Gravis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Myasthenia Gravis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Myasthenia Gravis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Myasthenia Gravis Treatment Market Dynamics
2.3.1 Myasthenia Gravis Treatment Industry Trends
2.3.2 Myasthenia Gravis Treatment Market Drivers
2.3.3 Myasthenia Gravis Treatment Market Challenges
2.3.4 Myasthenia Gravis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Myasthenia Gravis Treatment by Players
3.1.1 Global Myasthenia Gravis Treatment Revenue by Players (2019-2024)
3.1.2 Global Myasthenia Gravis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Myasthenia Gravis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Myasthenia Gravis Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Myasthenia Gravis Treatment Market Concentration Ratio
3.4.1 Global Myasthenia Gravis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Treatment Revenue in 2023
3.5 Global Key Players of Myasthenia Gravis Treatment Head office and Area Served
3.6 Global Key Players of Myasthenia Gravis Treatment, Product and Application
3.7 Global Key Players of Myasthenia Gravis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Myasthenia Gravis Treatment Breakdown Data by Type
4.1 Global Myasthenia Gravis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Myasthenia Gravis Treatment Forecasted Market Size by Type (2025-2030)
5 Myasthenia Gravis Treatment Breakdown Data by Application
5.1 Global Myasthenia Gravis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Myasthenia Gravis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Myasthenia Gravis Treatment Market Size (2019-2030)
6.2 North America Myasthenia Gravis Treatment Market Size by Type
6.2.1 North America Myasthenia Gravis Treatment Market Size by Type (2019-2024)
6.2.2 North America Myasthenia Gravis Treatment Market Size by Type (2025-2030)
6.2.3 North America Myasthenia Gravis Treatment Market Share by Type (2019-2030)
6.3 North America Myasthenia Gravis Treatment Market Size by Application
6.3.1 North America Myasthenia Gravis Treatment Market Size by Application (2019-2024)
6.3.2 North America Myasthenia Gravis Treatment Market Size by Application (2025-2030)
6.3.3 North America Myasthenia Gravis Treatment Market Share by Application (2019-2030)
6.4 North America Myasthenia Gravis Treatment Market Size by Country
6.4.1 North America Myasthenia Gravis Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Myasthenia Gravis Treatment Market Size by Country (2019-2024)
6.4.3 North America Myasthenia Gravis Treatment Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Myasthenia Gravis Treatment Market Size (2019-2030)
7.2 Europe Myasthenia Gravis Treatment Market Size by Type
7.2.1 Europe Myasthenia Gravis Treatment Market Size by Type (2019-2024)
7.2.2 Europe Myasthenia Gravis Treatment Market Size by Type (2025-2030)
7.2.3 Europe Myasthenia Gravis Treatment Market Share by Type (2019-2030)
7.3 Europe Myasthenia Gravis Treatment Market Size by Application
7.3.1 Europe Myasthenia Gravis Treatment Market Size by Application (2019-2024)
7.3.2 Europe Myasthenia Gravis Treatment Market Size by Application (2025-2030)
7.3.3 Europe Myasthenia Gravis Treatment Market Share by Application (2019-2030)
7.4 Europe Myasthenia Gravis Treatment Market Size by Country
7.4.1 Europe Myasthenia Gravis Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Myasthenia Gravis Treatment Market Size by Country (2019-2024)
7.4.3 Europe Myasthenia Gravis Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Myasthenia Gravis Treatment Market Size (2019-2030)
8.2 China Myasthenia Gravis Treatment Market Size by Type
8.2.1 China Myasthenia Gravis Treatment Market Size by Type (2019-2024)
8.2.2 China Myasthenia Gravis Treatment Market Size by Type (2025-2030)
8.2.3 China Myasthenia Gravis Treatment Market Share by Type (2019-2030)
8.3 China Myasthenia Gravis Treatment Market Size by Application
8.3.1 China Myasthenia Gravis Treatment Market Size by Application (2019-2024)
8.3.2 China Myasthenia Gravis Treatment Market Size by Application (2025-2030)
8.3.3 China Myasthenia Gravis Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Myasthenia Gravis Treatment Market Size (2019-2030)
9.2 Asia Myasthenia Gravis Treatment Market Size by Type
9.2.1 Asia Myasthenia Gravis Treatment Market Size by Type (2019-2024)
9.2.2 Asia Myasthenia Gravis Treatment Market Size by Type (2025-2030)
9.2.3 Asia Myasthenia Gravis Treatment Market Share by Type (2019-2030)
9.3 Asia Myasthenia Gravis Treatment Market Size by Application
9.3.1 Asia Myasthenia Gravis Treatment Market Size by Application (2019-2024)
9.3.2 Asia Myasthenia Gravis Treatment Market Size by Application (2025-2030)
9.3.3 Asia Myasthenia Gravis Treatment Market Share by Application (2019-2030)
9.4 Asia Myasthenia Gravis Treatment Market Size by Region
9.4.1 Asia Myasthenia Gravis Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Myasthenia Gravis Treatment Market Size by Region (2019-2024)
9.4.3 Asia Myasthenia Gravis Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Alexion Pharmaceutical Inc.
11.1.1 Alexion Pharmaceutical Inc. Company Details
11.1.2 Alexion Pharmaceutical Inc. Business Overview
11.1.3 Alexion Pharmaceutical Inc. Myasthenia Gravis Treatment Introduction
11.1.4 Alexion Pharmaceutical Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.1.5 Alexion Pharmaceutical Inc. Recent Developments
11.2 Grifols SA
11.2.1 Grifols SA Company Details
11.2.2 Grifols SA Business Overview
11.2.3 Grifols SA Myasthenia Gravis Treatment Introduction
11.2.4 Grifols SA Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.2.5 Grifols SA Recent Developments
11.3 Avadel Pharmaceuticals plc.
11.3.1 Avadel Pharmaceuticals plc. Company Details
11.3.2 Avadel Pharmaceuticals plc. Business Overview
11.3.3 Avadel Pharmaceuticals plc. Myasthenia Gravis Treatment Introduction
11.3.4 Avadel Pharmaceuticals plc. Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.3.5 Avadel Pharmaceuticals plc. Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Myasthenia Gravis Treatment Introduction
11.4.4 Novartis AG Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.4.5 Novartis AG Recent Developments
11.5 Pfizer; Inc.
11.5.1 Pfizer; Inc. Company Details
11.5.2 Pfizer; Inc. Business Overview
11.5.3 Pfizer; Inc. Myasthenia Gravis Treatment Introduction
11.5.4 Pfizer; Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.5.5 Pfizer; Inc. Recent Developments
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Details
11.6.2 AbbVie Inc. Business Overview
11.6.3 AbbVie Inc. Myasthenia Gravis Treatment Introduction
11.6.4 AbbVie Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.6.5 AbbVie Inc. Recent Developments
11.7 F. Hoffmann-La Roche Ltd.
11.7.1 F. Hoffmann-La Roche Ltd. Company Details
11.7.2 F. Hoffmann-La Roche Ltd. Business Overview
11.7.3 F. Hoffmann-La Roche Ltd. Myasthenia Gravis Treatment Introduction
11.7.4 F. Hoffmann-La Roche Ltd. Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.7.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.8 GlaxoSmithKline plc
11.8.1 GlaxoSmithKline plc Company Details
11.8.2 GlaxoSmithKline plc Business Overview
11.8.3 GlaxoSmithKline plc Myasthenia Gravis Treatment Introduction
11.8.4 GlaxoSmithKline plc Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.8.5 GlaxoSmithKline plc Recent Developments
11.9 Bausch Health Companies Inc.
11.9.1 Bausch Health Companies Inc. Company Details
11.9.2 Bausch Health Companies Inc. Business Overview
11.9.3 Bausch Health Companies Inc. Myasthenia Gravis Treatment Introduction
11.9.4 Bausch Health Companies Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.9.5 Bausch Health Companies Inc. Recent Developments
11.10 Shire plc.
11.10.1 Shire plc. Company Details
11.10.2 Shire plc. Business Overview
11.10.3 Shire plc. Myasthenia Gravis Treatment Introduction
11.10.4 Shire plc. Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.10.5 Shire plc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myasthenia Gravis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Medication
1.2.3 Surgery
1.3 Market by Application
1.3.1 Global Myasthenia Gravis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Myasthenia Gravis Treatment Market Perspective (2019-2030)
2.2 Global Myasthenia Gravis Treatment Growth Trends by Region
2.2.1 Myasthenia Gravis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Myasthenia Gravis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Myasthenia Gravis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Myasthenia Gravis Treatment Market Dynamics
2.3.1 Myasthenia Gravis Treatment Industry Trends
2.3.2 Myasthenia Gravis Treatment Market Drivers
2.3.3 Myasthenia Gravis Treatment Market Challenges
2.3.4 Myasthenia Gravis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Myasthenia Gravis Treatment by Players
3.1.1 Global Myasthenia Gravis Treatment Revenue by Players (2019-2024)
3.1.2 Global Myasthenia Gravis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Myasthenia Gravis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Myasthenia Gravis Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Myasthenia Gravis Treatment Market Concentration Ratio
3.4.1 Global Myasthenia Gravis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Treatment Revenue in 2023
3.5 Global Key Players of Myasthenia Gravis Treatment Head office and Area Served
3.6 Global Key Players of Myasthenia Gravis Treatment, Product and Application
3.7 Global Key Players of Myasthenia Gravis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Myasthenia Gravis Treatment Breakdown Data by Type
4.1 Global Myasthenia Gravis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Myasthenia Gravis Treatment Forecasted Market Size by Type (2025-2030)
5 Myasthenia Gravis Treatment Breakdown Data by Application
5.1 Global Myasthenia Gravis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Myasthenia Gravis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Myasthenia Gravis Treatment Market Size (2019-2030)
6.2 North America Myasthenia Gravis Treatment Market Size by Type
6.2.1 North America Myasthenia Gravis Treatment Market Size by Type (2019-2024)
6.2.2 North America Myasthenia Gravis Treatment Market Size by Type (2025-2030)
6.2.3 North America Myasthenia Gravis Treatment Market Share by Type (2019-2030)
6.3 North America Myasthenia Gravis Treatment Market Size by Application
6.3.1 North America Myasthenia Gravis Treatment Market Size by Application (2019-2024)
6.3.2 North America Myasthenia Gravis Treatment Market Size by Application (2025-2030)
6.3.3 North America Myasthenia Gravis Treatment Market Share by Application (2019-2030)
6.4 North America Myasthenia Gravis Treatment Market Size by Country
6.4.1 North America Myasthenia Gravis Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Myasthenia Gravis Treatment Market Size by Country (2019-2024)
6.4.3 North America Myasthenia Gravis Treatment Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Myasthenia Gravis Treatment Market Size (2019-2030)
7.2 Europe Myasthenia Gravis Treatment Market Size by Type
7.2.1 Europe Myasthenia Gravis Treatment Market Size by Type (2019-2024)
7.2.2 Europe Myasthenia Gravis Treatment Market Size by Type (2025-2030)
7.2.3 Europe Myasthenia Gravis Treatment Market Share by Type (2019-2030)
7.3 Europe Myasthenia Gravis Treatment Market Size by Application
7.3.1 Europe Myasthenia Gravis Treatment Market Size by Application (2019-2024)
7.3.2 Europe Myasthenia Gravis Treatment Market Size by Application (2025-2030)
7.3.3 Europe Myasthenia Gravis Treatment Market Share by Application (2019-2030)
7.4 Europe Myasthenia Gravis Treatment Market Size by Country
7.4.1 Europe Myasthenia Gravis Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Myasthenia Gravis Treatment Market Size by Country (2019-2024)
7.4.3 Europe Myasthenia Gravis Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Myasthenia Gravis Treatment Market Size (2019-2030)
8.2 China Myasthenia Gravis Treatment Market Size by Type
8.2.1 China Myasthenia Gravis Treatment Market Size by Type (2019-2024)
8.2.2 China Myasthenia Gravis Treatment Market Size by Type (2025-2030)
8.2.3 China Myasthenia Gravis Treatment Market Share by Type (2019-2030)
8.3 China Myasthenia Gravis Treatment Market Size by Application
8.3.1 China Myasthenia Gravis Treatment Market Size by Application (2019-2024)
8.3.2 China Myasthenia Gravis Treatment Market Size by Application (2025-2030)
8.3.3 China Myasthenia Gravis Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Myasthenia Gravis Treatment Market Size (2019-2030)
9.2 Asia Myasthenia Gravis Treatment Market Size by Type
9.2.1 Asia Myasthenia Gravis Treatment Market Size by Type (2019-2024)
9.2.2 Asia Myasthenia Gravis Treatment Market Size by Type (2025-2030)
9.2.3 Asia Myasthenia Gravis Treatment Market Share by Type (2019-2030)
9.3 Asia Myasthenia Gravis Treatment Market Size by Application
9.3.1 Asia Myasthenia Gravis Treatment Market Size by Application (2019-2024)
9.3.2 Asia Myasthenia Gravis Treatment Market Size by Application (2025-2030)
9.3.3 Asia Myasthenia Gravis Treatment Market Share by Application (2019-2030)
9.4 Asia Myasthenia Gravis Treatment Market Size by Region
9.4.1 Asia Myasthenia Gravis Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Myasthenia Gravis Treatment Market Size by Region (2019-2024)
9.4.3 Asia Myasthenia Gravis Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Alexion Pharmaceutical Inc.
11.1.1 Alexion Pharmaceutical Inc. Company Details
11.1.2 Alexion Pharmaceutical Inc. Business Overview
11.1.3 Alexion Pharmaceutical Inc. Myasthenia Gravis Treatment Introduction
11.1.4 Alexion Pharmaceutical Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.1.5 Alexion Pharmaceutical Inc. Recent Developments
11.2 Grifols SA
11.2.1 Grifols SA Company Details
11.2.2 Grifols SA Business Overview
11.2.3 Grifols SA Myasthenia Gravis Treatment Introduction
11.2.4 Grifols SA Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.2.5 Grifols SA Recent Developments
11.3 Avadel Pharmaceuticals plc.
11.3.1 Avadel Pharmaceuticals plc. Company Details
11.3.2 Avadel Pharmaceuticals plc. Business Overview
11.3.3 Avadel Pharmaceuticals plc. Myasthenia Gravis Treatment Introduction
11.3.4 Avadel Pharmaceuticals plc. Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.3.5 Avadel Pharmaceuticals plc. Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Myasthenia Gravis Treatment Introduction
11.4.4 Novartis AG Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.4.5 Novartis AG Recent Developments
11.5 Pfizer; Inc.
11.5.1 Pfizer; Inc. Company Details
11.5.2 Pfizer; Inc. Business Overview
11.5.3 Pfizer; Inc. Myasthenia Gravis Treatment Introduction
11.5.4 Pfizer; Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.5.5 Pfizer; Inc. Recent Developments
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Details
11.6.2 AbbVie Inc. Business Overview
11.6.3 AbbVie Inc. Myasthenia Gravis Treatment Introduction
11.6.4 AbbVie Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.6.5 AbbVie Inc. Recent Developments
11.7 F. Hoffmann-La Roche Ltd.
11.7.1 F. Hoffmann-La Roche Ltd. Company Details
11.7.2 F. Hoffmann-La Roche Ltd. Business Overview
11.7.3 F. Hoffmann-La Roche Ltd. Myasthenia Gravis Treatment Introduction
11.7.4 F. Hoffmann-La Roche Ltd. Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.7.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.8 GlaxoSmithKline plc
11.8.1 GlaxoSmithKline plc Company Details
11.8.2 GlaxoSmithKline plc Business Overview
11.8.3 GlaxoSmithKline plc Myasthenia Gravis Treatment Introduction
11.8.4 GlaxoSmithKline plc Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.8.5 GlaxoSmithKline plc Recent Developments
11.9 Bausch Health Companies Inc.
11.9.1 Bausch Health Companies Inc. Company Details
11.9.2 Bausch Health Companies Inc. Business Overview
11.9.3 Bausch Health Companies Inc. Myasthenia Gravis Treatment Introduction
11.9.4 Bausch Health Companies Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.9.5 Bausch Health Companies Inc. Recent Developments
11.10 Shire plc.
11.10.1 Shire plc. Company Details
11.10.2 Shire plc. Business Overview
11.10.3 Shire plc. Myasthenia Gravis Treatment Introduction
11.10.4 Shire plc. Revenue in Myasthenia Gravis Treatment Business (2019-2024)
11.10.5 Shire plc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Myasthenia Gravis Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Medication
Table 3. Key Players of Surgery
Table 4. Global Myasthenia Gravis Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Myasthenia Gravis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Myasthenia Gravis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Myasthenia Gravis Treatment Market Share by Region (2019-2024)
Table 8. Global Myasthenia Gravis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Myasthenia Gravis Treatment Market Share by Region (2025-2030)
Table 10. Myasthenia Gravis Treatment Market Trends
Table 11. Myasthenia Gravis Treatment Market Drivers
Table 12. Myasthenia Gravis Treatment Market Challenges
Table 13. Myasthenia Gravis Treatment Market Restraints
Table 14. Global Myasthenia Gravis Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Myasthenia Gravis Treatment Revenue Share by Players (2019-2024)
Table 16. Global Top Myasthenia Gravis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis Treatment as of 2023)
Table 17. Global Myasthenia Gravis Treatment Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Myasthenia Gravis Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Myasthenia Gravis Treatment, Headquarters and Area Served
Table 20. Global Key Players of Myasthenia Gravis Treatment, Product and Application
Table 21. Global Key Players of Myasthenia Gravis Treatment, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Myasthenia Gravis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Myasthenia Gravis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Myasthenia Gravis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Myasthenia Gravis Treatment Revenue Share by Application (2019-2024)
Table 29. Global Myasthenia Gravis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Myasthenia Gravis Treatment Revenue Share by Application (2025-2030)
Table 31. North America Myasthenia Gravis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Myasthenia Gravis Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Myasthenia Gravis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Myasthenia Gravis Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Myasthenia Gravis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Myasthenia Gravis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Myasthenia Gravis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Myasthenia Gravis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Myasthenia Gravis Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Myasthenia Gravis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Myasthenia Gravis Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Myasthenia Gravis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Myasthenia Gravis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Myasthenia Gravis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Myasthenia Gravis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Myasthenia Gravis Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Myasthenia Gravis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Myasthenia Gravis Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Myasthenia Gravis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Myasthenia Gravis Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Myasthenia Gravis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Myasthenia Gravis Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Myasthenia Gravis Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Myasthenia Gravis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Myasthenia Gravis Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 63. Alexion Pharmaceutical Inc. Company Details
Table 64. Alexion Pharmaceutical Inc. Business Overview
Table 65. Alexion Pharmaceutical Inc. Myasthenia Gravis Treatment Product
Table 66. Alexion Pharmaceutical Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 67. Alexion Pharmaceutical Inc. Recent Developments
Table 68. Grifols SA Company Details
Table 69. Grifols SA Business Overview
Table 70. Grifols SA Myasthenia Gravis Treatment Product
Table 71. Grifols SA Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 72. Grifols SA Recent Developments
Table 73. Avadel Pharmaceuticals plc. Company Details
Table 74. Avadel Pharmaceuticals plc. Business Overview
Table 75. Avadel Pharmaceuticals plc. Myasthenia Gravis Treatment Product
Table 76. Avadel Pharmaceuticals plc. Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 77. Avadel Pharmaceuticals plc. Recent Developments
Table 78. Novartis AG Company Details
Table 79. Novartis AG Business Overview
Table 80. Novartis AG Myasthenia Gravis Treatment Product
Table 81. Novartis AG Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 82. Novartis AG Recent Developments
Table 83. Pfizer; Inc. Company Details
Table 84. Pfizer; Inc. Business Overview
Table 85. Pfizer; Inc. Myasthenia Gravis Treatment Product
Table 86. Pfizer; Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 87. Pfizer; Inc. Recent Developments
Table 88. AbbVie Inc. Company Details
Table 89. AbbVie Inc. Business Overview
Table 90. AbbVie Inc. Myasthenia Gravis Treatment Product
Table 91. AbbVie Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 92. AbbVie Inc. Recent Developments
Table 93. F. Hoffmann-La Roche Ltd. Company Details
Table 94. F. Hoffmann-La Roche Ltd. Business Overview
Table 95. F. Hoffmann-La Roche Ltd. Myasthenia Gravis Treatment Product
Table 96. F. Hoffmann-La Roche Ltd. Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 97. F. Hoffmann-La Roche Ltd. Recent Developments
Table 98. GlaxoSmithKline plc Company Details
Table 99. GlaxoSmithKline plc Business Overview
Table 100. GlaxoSmithKline plc Myasthenia Gravis Treatment Product
Table 101. GlaxoSmithKline plc Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 102. GlaxoSmithKline plc Recent Developments
Table 103. Bausch Health Companies Inc. Company Details
Table 104. Bausch Health Companies Inc. Business Overview
Table 105. Bausch Health Companies Inc. Myasthenia Gravis Treatment Product
Table 106. Bausch Health Companies Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 107. Bausch Health Companies Inc. Recent Developments
Table 108. Shire plc. Company Details
Table 109. Shire plc. Business Overview
Table 110. Shire plc. Myasthenia Gravis Treatment Product
Table 111. Shire plc. Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 112. Shire plc. Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Myasthenia Gravis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Myasthenia Gravis Treatment Market Share by Type: 2023 VS 2030
Figure 3. Medication Features
Figure 4. Surgery Features
Figure 5. Global Myasthenia Gravis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Myasthenia Gravis Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Myasthenia Gravis Treatment Report Years Considered
Figure 11. Global Myasthenia Gravis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Myasthenia Gravis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Myasthenia Gravis Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Myasthenia Gravis Treatment Market Share by Players in 2023
Figure 15. Global Top Myasthenia Gravis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Myasthenia Gravis Treatment Revenue in 2023
Figure 17. North America Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Myasthenia Gravis Treatment Market Share by Type (2019-2030)
Figure 19. North America Myasthenia Gravis Treatment Market Share by Application (2019-2030)
Figure 20. North America Myasthenia Gravis Treatment Market Share by Country (2019-2030)
Figure 21. United States Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Myasthenia Gravis Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 24. Europe Myasthenia Gravis Treatment Market Share by Type (2019-2030)
Figure 25. Europe Myasthenia Gravis Treatment Market Share by Application (2019-2030)
Figure 26. Europe Myasthenia Gravis Treatment Market Share by Country (2019-2030)
Figure 27. Germany Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. China Myasthenia Gravis Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 34. China Myasthenia Gravis Treatment Market Share by Type (2019-2030)
Figure 35. China Myasthenia Gravis Treatment Market Share by Application (2019-2030)
Figure 36. Asia Myasthenia Gravis Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 37. Asia Myasthenia Gravis Treatment Market Share by Type (2019-2030)
Figure 38. Asia Myasthenia Gravis Treatment Market Share by Application (2019-2030)
Figure 39. Asia Myasthenia Gravis Treatment Market Share by Region (2019-2030)
Figure 40. Japan Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Taiwan Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Share by Type (2019-2030)
Figure 48. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Share by Application (2019-2030)
Figure 49. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Share by Country (2019-2030)
Figure 50. Brazil Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Mexico Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Turkey Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Israel Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. GCC Countries Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Alexion Pharmaceutical Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 57. Grifols SA Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 58. Avadel Pharmaceuticals plc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 59. Novartis AG Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 60. Pfizer; Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 61. AbbVie Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 62. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 63. GlaxoSmithKline plc Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 64. Bausch Health Companies Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 65. Shire plc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Myasthenia Gravis Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Medication
Table 3. Key Players of Surgery
Table 4. Global Myasthenia Gravis Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Myasthenia Gravis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Myasthenia Gravis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Myasthenia Gravis Treatment Market Share by Region (2019-2024)
Table 8. Global Myasthenia Gravis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Myasthenia Gravis Treatment Market Share by Region (2025-2030)
Table 10. Myasthenia Gravis Treatment Market Trends
Table 11. Myasthenia Gravis Treatment Market Drivers
Table 12. Myasthenia Gravis Treatment Market Challenges
Table 13. Myasthenia Gravis Treatment Market Restraints
Table 14. Global Myasthenia Gravis Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Myasthenia Gravis Treatment Revenue Share by Players (2019-2024)
Table 16. Global Top Myasthenia Gravis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis Treatment as of 2023)
Table 17. Global Myasthenia Gravis Treatment Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Myasthenia Gravis Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Myasthenia Gravis Treatment, Headquarters and Area Served
Table 20. Global Key Players of Myasthenia Gravis Treatment, Product and Application
Table 21. Global Key Players of Myasthenia Gravis Treatment, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Myasthenia Gravis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Myasthenia Gravis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Myasthenia Gravis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Myasthenia Gravis Treatment Revenue Share by Application (2019-2024)
Table 29. Global Myasthenia Gravis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Myasthenia Gravis Treatment Revenue Share by Application (2025-2030)
Table 31. North America Myasthenia Gravis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Myasthenia Gravis Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Myasthenia Gravis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Myasthenia Gravis Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Myasthenia Gravis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Myasthenia Gravis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Myasthenia Gravis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Myasthenia Gravis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Myasthenia Gravis Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Myasthenia Gravis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Myasthenia Gravis Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Myasthenia Gravis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Myasthenia Gravis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Myasthenia Gravis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Myasthenia Gravis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Myasthenia Gravis Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Myasthenia Gravis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Myasthenia Gravis Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Myasthenia Gravis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Myasthenia Gravis Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Myasthenia Gravis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Myasthenia Gravis Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Myasthenia Gravis Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Myasthenia Gravis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Myasthenia Gravis Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 63. Alexion Pharmaceutical Inc. Company Details
Table 64. Alexion Pharmaceutical Inc. Business Overview
Table 65. Alexion Pharmaceutical Inc. Myasthenia Gravis Treatment Product
Table 66. Alexion Pharmaceutical Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 67. Alexion Pharmaceutical Inc. Recent Developments
Table 68. Grifols SA Company Details
Table 69. Grifols SA Business Overview
Table 70. Grifols SA Myasthenia Gravis Treatment Product
Table 71. Grifols SA Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 72. Grifols SA Recent Developments
Table 73. Avadel Pharmaceuticals plc. Company Details
Table 74. Avadel Pharmaceuticals plc. Business Overview
Table 75. Avadel Pharmaceuticals plc. Myasthenia Gravis Treatment Product
Table 76. Avadel Pharmaceuticals plc. Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 77. Avadel Pharmaceuticals plc. Recent Developments
Table 78. Novartis AG Company Details
Table 79. Novartis AG Business Overview
Table 80. Novartis AG Myasthenia Gravis Treatment Product
Table 81. Novartis AG Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 82. Novartis AG Recent Developments
Table 83. Pfizer; Inc. Company Details
Table 84. Pfizer; Inc. Business Overview
Table 85. Pfizer; Inc. Myasthenia Gravis Treatment Product
Table 86. Pfizer; Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 87. Pfizer; Inc. Recent Developments
Table 88. AbbVie Inc. Company Details
Table 89. AbbVie Inc. Business Overview
Table 90. AbbVie Inc. Myasthenia Gravis Treatment Product
Table 91. AbbVie Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 92. AbbVie Inc. Recent Developments
Table 93. F. Hoffmann-La Roche Ltd. Company Details
Table 94. F. Hoffmann-La Roche Ltd. Business Overview
Table 95. F. Hoffmann-La Roche Ltd. Myasthenia Gravis Treatment Product
Table 96. F. Hoffmann-La Roche Ltd. Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 97. F. Hoffmann-La Roche Ltd. Recent Developments
Table 98. GlaxoSmithKline plc Company Details
Table 99. GlaxoSmithKline plc Business Overview
Table 100. GlaxoSmithKline plc Myasthenia Gravis Treatment Product
Table 101. GlaxoSmithKline plc Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 102. GlaxoSmithKline plc Recent Developments
Table 103. Bausch Health Companies Inc. Company Details
Table 104. Bausch Health Companies Inc. Business Overview
Table 105. Bausch Health Companies Inc. Myasthenia Gravis Treatment Product
Table 106. Bausch Health Companies Inc. Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 107. Bausch Health Companies Inc. Recent Developments
Table 108. Shire plc. Company Details
Table 109. Shire plc. Business Overview
Table 110. Shire plc. Myasthenia Gravis Treatment Product
Table 111. Shire plc. Revenue in Myasthenia Gravis Treatment Business (2019-2024) & (US$ Million)
Table 112. Shire plc. Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Myasthenia Gravis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Myasthenia Gravis Treatment Market Share by Type: 2023 VS 2030
Figure 3. Medication Features
Figure 4. Surgery Features
Figure 5. Global Myasthenia Gravis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Myasthenia Gravis Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Myasthenia Gravis Treatment Report Years Considered
Figure 11. Global Myasthenia Gravis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Myasthenia Gravis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Myasthenia Gravis Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Myasthenia Gravis Treatment Market Share by Players in 2023
Figure 15. Global Top Myasthenia Gravis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Myasthenia Gravis Treatment Revenue in 2023
Figure 17. North America Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Myasthenia Gravis Treatment Market Share by Type (2019-2030)
Figure 19. North America Myasthenia Gravis Treatment Market Share by Application (2019-2030)
Figure 20. North America Myasthenia Gravis Treatment Market Share by Country (2019-2030)
Figure 21. United States Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Myasthenia Gravis Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 24. Europe Myasthenia Gravis Treatment Market Share by Type (2019-2030)
Figure 25. Europe Myasthenia Gravis Treatment Market Share by Application (2019-2030)
Figure 26. Europe Myasthenia Gravis Treatment Market Share by Country (2019-2030)
Figure 27. Germany Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. China Myasthenia Gravis Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 34. China Myasthenia Gravis Treatment Market Share by Type (2019-2030)
Figure 35. China Myasthenia Gravis Treatment Market Share by Application (2019-2030)
Figure 36. Asia Myasthenia Gravis Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 37. Asia Myasthenia Gravis Treatment Market Share by Type (2019-2030)
Figure 38. Asia Myasthenia Gravis Treatment Market Share by Application (2019-2030)
Figure 39. Asia Myasthenia Gravis Treatment Market Share by Region (2019-2030)
Figure 40. Japan Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Taiwan Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Share by Type (2019-2030)
Figure 48. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Share by Application (2019-2030)
Figure 49. Middle East, Africa, and Latin America Myasthenia Gravis Treatment Market Share by Country (2019-2030)
Figure 50. Brazil Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Mexico Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Turkey Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Israel Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. GCC Countries Myasthenia Gravis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Alexion Pharmaceutical Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 57. Grifols SA Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 58. Avadel Pharmaceuticals plc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 59. Novartis AG Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 60. Pfizer; Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 61. AbbVie Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 62. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 63. GlaxoSmithKline plc Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 64. Bausch Health Companies Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 65. Shire plc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Computer-Controlled Local Anesthetics Delivery Market Research Report 2025
May 20, 25
Global Barb and Cone Thread Market Research Report 2025
May 20, 25
Global MIYABI Angio-CT Market Research Report 2025
May 20, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232